Burning Rock Biotech (BNR) Operating Expenses: 2020-2025
Historic Operating Expenses for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to -$16.4 million.
- Burning Rock Biotech's Operating Expenses rose 20.73% to -$16.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$69.2 million, marking a year-over-year increase of 40.11%. This contributed to the annual value of -$98.6 million for FY2024, which is 32.18% up from last year.
- Burning Rock Biotech's Operating Expenses amounted to -$16.4 million in Q3 2025, which was up 3.21% from -$16.9 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Operating Expenses ranged from a high of -$15.5 million in Q1 2025 and a low of -$57.5 million during Q4 2021.
- Its 3-year average for Operating Expenses is -$26.6 million, with a median of -$28.2 million in 2024.
- In the last 5 years, Burning Rock Biotech's Operating Expenses tumbled by 45.57% in 2022 and then surged by 47.04% in 2025.
- MRQ analysis of 5 years shows Burning Rock Biotech's Operating Expenses stood at -$57.5 million in 2021, then grew by 11.63% to -$50.8 million in 2022, then increased by 26.36% to -$37.4 million in 2023, then soared by 45.32% to -$20.5 million in 2024, then grew by 20.06% to -$16.4 million in 2025.
- Its Operating Expenses was -$16.4 million in Q3 2025, compared to -$16.9 million in Q2 2025 and -$15.5 million in Q1 2025.